The Daegu-Gyeongbuk Free Economic Zone Authority announced on July 13 that it had discussed ways to expand foreign investment attraction with the National Institute for Korean Medicine Development.


The National Institute for Korean Medicine Development is the only institution in Korea dedicated to promoting the Korean medicine industry. It was established in June 2019 under the "Korean Medicine Promotion Act" and is a public organization under the Ministry of Health and Welfare. Through the advancement and technological development of Korean medicine, as well as industrial promotion, the institute contributes to public health and national economic growth. Its main office is located in Gyeongsan-si, Gyeongbuk Province, and the herbal medicine production center is situated in the Sinseo Advanced Medical District in Daegu.

Kang Sangki, Acting Commissioner of Daegu Gyeongbuk Economic Free Zone Authority (left), and Ko Hoyon, President of the National Institute for Korean Medicine Development, shook hands and discussed strategies for attracting global companies.

Kang Sangki, Acting Commissioner of Daegu Gyeongbuk Economic Free Zone Authority (left), and Ko Hoyon, President of the National Institute for Korean Medicine Development, shook hands and discussed strategies for attracting global companies.

View original image

On this day, Kang Sangki, Acting Commissioner of the Daegu-Gyeongbuk Free Economic Zone Authority, received a briefing on the institute's global business from Ko Hoyon, President of the National Institute for Korean Medicine Development, and toured the main facilities. They also discussed various cooperation initiatives, including holding joint overseas investment roadshows (IR) to attract global medical and bio companies.



Acting Commissioner Kang Sangki commented, "I am well aware that the National Institute for Korean Medicine Development is working hard to enhance the global competitiveness of the Korean medicine industry. The Daegu-Gyeongbuk Free Economic Zone Authority will also expand efforts to attract related global medical and bio companies to contribute to the development of the local industry."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing